Samalin Investment Counsel’s Sanofi SNY Stock Holding History

Samalin Investment Counsel’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-101	Closed	-$5K	–	460
2019 Q4	$5K	Buy	+101	New	+$4.73K	﹤0.01%	472

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Samalin Investment Counsel's SNY Position: Q1 2020 in Review

Samalin Investment Counsel sold out of Sanofi (SNY) in Q1 2020, closing a stake of 101 shares — an estimated $5K sold.

Samalin Investment Counsel first reported a position in SNY in Q4 2019 and held it in 1 quarter. The position peaked at $5K in Q4 2019. 547 funds tracked by Wall St. Rank hold SNY as of Q1 2020.

Samalin Investment Counsel reported no remaining Sanofi position as of Q1 2020 after selling out during the quarter.
Samalin Investment Counsel sold 101 Sanofi shares in Q1 2020, an estimated $5K.
Samalin Investment Counsel first reported a position in Sanofi in Q4 2019 and held it in 1 quarter.
Samalin Investment Counsel's Sanofi position peaked at $5K in Q4 2019.
547 funds tracked by Wall St. Rank held Sanofi as of Q1 2020.

Based on Samalin Investment Counsel's 13F filing for Q1 2020, filed 4 May 2020.